SCHEMBL21523331

SCHEMBL21523331

CCCCCCCCCCCCCCCCCCCCCc1[c]cccc1CCCCCCCCCCCCCCCCCCCCC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 1/20 0.49
KCNH2 Q12809 2/20 0.43
BID P55957 3/20 0.41
MCL1 Q07820 3/20 0.41
PPARA Q07869 3/20 0.41
BCL2L1 Q07817 2/20 0.41
BAK1 Q16611 2/20 0.41
KAT8 Q9H7Z6 2/20 0.41
PPARG P37231 2/20 0.41
EP300 Q09472 1/20 0.41
KAT2A Q92830 1/20 0.41
KAT2B Q92831 1/20 0.41
KAT5 Q92993 1/20 0.41
SAE1 Q9UBE0 1/20 0.41
NR1H2 P55055 1/20 0.41
NR1H3 Q13133 1/20 0.41
ALOX5 P09917 2/20 0.40
PTGS2 P35354 1/20 0.40
TYR P14679 2/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21523367 1.00 LIPG (0.49) LIPGKCNH2BIDMCL1PPARA
SCHEMBL21523330 1.00 LIPG (0.49) LIPGKCNH2BIDMCL1PPARA
SCHEMBL21523361 1.00 LIPG (0.49) LIPGKCNH2BIDMCL1PPARA
SCHEMBL21523356 1.00 LIPG (0.49) LIPGKCNH2BIDMCL1PPARA
SCHEMBL21523320 1.00 LIPG (0.49) LIPGKCNH2BIDMCL1PPARA
SCHEMBL21523328 1.00 LIPG (0.49) LIPGKCNH2BIDMCL1PPARA
SCHEMBL21523319 1.00 LIPG (0.49) LIPGKCNH2BIDMCL1PPARA
SCHEMBL21523321 1.00 LIPG (0.49) LIPGKCNH2BIDMCL1PPARA
SCHEMBL21523363 1.00 LIPG (0.49) LIPGKCNH2BIDMCL1PPARA
SCHEMBL21523337 1.00 LIPG (0.49) LIPGKCNH2BIDMCL1PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11572423-B2 Processes for introduction of liquid activators in olefin polymerization reactions EXXONMOBIL CHEMICALS PATENTS INC. (US) 2023-02-07 US disclosed
US-11414436-B2 Non-coordinating anion type activators containing cation having large alkyl groups EXXONMOBIL CHEMICAL PATENTS INC. (US) 2022-08-16 US disclosed
US-20210189022-A1 Processes for Introduction of Liquid Activators in Olefin Polymerization Reactions EXXONMOBIL CHEMICAL PATENTS INC (US) 2021-06-24 US disclosed
WO-2021119089-A1 PROCESSES FOR INTRODUCTION OF LIQUID ACTIVATORS IN OLEFIN POLYMERIZATION REACTIONS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2021-06-17 WO disclosed
EP-3784677-A1 NON-COORDINATING ANION TYPE ACTIVATORS CONTAINING CATION HAVING LARGE ALKYL GROUPS ExxonMobil Chemical Patents Inc. (US) 2021-03-03 EP disclosed
US-20190330139-A1 Non-Coordinating Anion Type Activators Containing Cation Having Large Alkyl Groups EXXONMOBIL CHEMICAL PATENTS INC. 2019-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11414436-B2 Non-coordinating anion type activators containing cation having large alkyl groups KCNK10, KCNK4, HCN4 LIPG 3697/4885KCNH2 26/4885BID 2562/4885
US-20190330139-A1 Non-Coordinating Anion Type Activators Containing Cation Having Large Alkyl Groups KCNK10, KCNK4, HCN4 LIPG 3676/4885KCNH2 25/4885BID 2562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.